Trial Profile
Open-Label, Multicenter, Phase I/II Trial to Evaluate Efficacy Safety of the Combination Therapy of Genexol-PM and Carboplatin as a Firstline Treatment in Subjects With Advanced Ovarian Cancer.
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Ovarian cancer
- Focus Adverse reactions; Therapeutic Use